3M completes sale of its drug delivery business
BOSTON: 3M has announced that it has completed the sale of substantially all of its drug delivery business to an affiliate of Altaris Capital Partners, LLC., for approximately $650 million in total. The consideration includes cash, an interest-bearing security, and a 17 percent noncontrolling interest in the new company, Kindeva Drug Delivery that will operate…